Commercial With oral obesity race underway, all eyes are on Lilly’s Foundayo launch BioSpaceNovo Nordisk's oral Wegovy has a few months' head start on Eli Lilly's newly approved pill.CommercialMetabolic & GLP-1Read full story pharminent April 10, 2026 (Last updated: April 10, 2026) BioSpace Novo Nordisk’s oral Wegovy has a few months’ head start on Eli Lilly’s newly approved pill. CommercialMetabolic & GLP-1Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Senju launches first-in-class dry eye disease drug in JapanNext: RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders Related Stories Commercial Leqembi sales grow again after subcutaneous approvals pharminent July 29, 2026 Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026 Commercial Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval pharminent June 26, 2026
